Zymeworks Inc. (ZYME) stock analysis

ZYME · Zymeworks Inc.

Latest recorded price: USD 26.45

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -36.4%, free cash flow margin -32.6%, ROIC -14.4%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare